PALB2 Mutation and Breast Cancer Risk
Author Information
Author(s): Southey Melissa C, Teo Zhi L, Dowty James G, Odefrey Fabrice A, Park Daniel J, Tischkowitz Marc, Sabbaghian Nelly, Apicella Carmel, Byrnes Graham B, Winship Ingrid, Baglietto Laura, Giles Graham G, Goldgar David E, Foulkes William D, Hopper John L
Primary Institution: The University of Melbourne
Hypothesis
How does the PALB2 mutation affect breast cancer risk in women?
Conclusion
The PALB2 c.3113G > A mutation is associated with significant breast cancer risks.
Supporting Evidence
- Five independent case probands with the PALB2 mutation were identified.
- Two of the probands were diagnosed with breast cancer before age 40.
- None of the 764 population-based controls carried the mutation.
- The hazard ratio for breast cancer risk was estimated to be 30.1.
- Cumulative risk estimates were 49% to age 50 and 91% to age 70.
Takeaway
Women with a specific PALB2 mutation have a much higher chance of getting breast cancer, especially if they have family members who also had it.
Methodology
Screening for PALB2 mutations in 1,403 women with breast cancer and analyzing family cancer histories.
Potential Biases
Potential bias in family history reporting and selection of participants.
Limitations
The study may not fully represent all populations due to its focus on Australian women.
Participant Demographics
Australian women diagnosed with invasive breast cancer, stratified by age.
Statistical Information
P-Value
<0.0001
Confidence Interval
95% CI, 7.5 to 120
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website